DIAGNOSTICA STAGO

Descripción

STA-Liatest D-Di Plus was developed as an evolution of the STA-Liatest D-Di, one of the most published D-Dimer assays, also FDA approved for aid in the diagnosis of Venous Thrombo Embolism (VTE). In STA-Liatest D-Di Plus, the addition of a blocking agent improves the analytical and diagnostic performances of the assay by minimizing interferences to heterophilic antibodies, including rheumatoid factors (RF) and Human Anti-Mouse Antibodies (HAMA). By minimizing the interferences from heterophilic antibodies, STA-Liatest D-Di Plus has been designed to show improved specificity for even more efficacy.